Skip to content

Comparison of Sedative Effect of Dexmedetomidine and Midazolam for TIVA

Comparison of Sedative Effect of Dexmedetomidine and Midazolam for TIVA in Pediatric Population Undergoing Inguinal Hernia Repair, Randomized Controlled Trial

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05574179
Enrollment
60
Registered
2022-10-10
Start date
2023-01-01
Completion date
2023-10-31
Last updated
2022-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choosing Better Drug Option for Sedation in Pediatric Population Intraoperatively

Brief summary

Comparison of sedative effects of dexmedetomidine and midazolam using ramsay sedation scores intraoperatively in children undergoing inguinal hernia repair.

Detailed description

a randomized controlled trial to compare the sesative effects of dexmedetomidine and midazolam in pediatric population planned for inguinal herna repair under TIVA in sheikh zayed hospital rahim yar khan.

Interventions

DRUGDexmedetomidine injection

Inj precedex 200mcg in 1ml given in stat doses

DRUGMidazolam

Inj.midazolam 5mg/5ml given in stat doses

Sponsors

Sheikh Zayed Medical College
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA I and II Age 6 to 12 years Any gender

Exclusion criteria

* ASA III and above Age less than 2 years and above 12 years Congenital heart disease Cardiac arrythmias Congenital abnormalities Respiratory disease Endocrine disorders Mental retardation Organ dysfunction Bleeding disorders Physician or family refusal Previous surgeries Allergy to any drug

Design outcomes

Primary

MeasureTime frame
Dexmedetomidine is better sedative agent than midazolam in pediatric population25 minutes

Secondary

MeasureTime frame
Midazolam is better sedating agent than dexmedetomidine in pediatric population25 minutes
Midazolam and dexmedetomidine are equally good sedating agents in pediatric population25 minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026